APA (7th ed.) Citation

R, L., M, B., IA, B., A, C., S, F., A, F., . . . S, B. (2025). The role of PSMA-based radioligand therapy in hormone-sensitive prostate cancer. European journal of nuclear medicine and molecular imaging, 52(7), 2723. https://doi.org/10.1007/s00259-025-07083-8

Chicago Style (17th ed.) Citation

R, Laudicella, et al. "The Role of PSMA-based Radioligand Therapy in Hormone-sensitive Prostate Cancer." European Journal of Nuclear Medicine and Molecular Imaging 52, no. 7 (2025): 2723. https://doi.org/10.1007/s00259-025-07083-8.

MLA (9th ed.) Citation

R, Laudicella, et al. "The Role of PSMA-based Radioligand Therapy in Hormone-sensitive Prostate Cancer." European Journal of Nuclear Medicine and Molecular Imaging, vol. 52, no. 7, 2025, p. 2723, https://doi.org/10.1007/s00259-025-07083-8.